Hybrid Janus Microparticles Achieving Selective Encapsulation for Theranostic Applications via a Facile Solvent Emulsion Method
Yi Guang Jerome Lim
School of Materials Science and Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore, 639798
Search for more papers by this authorKwok Choon Wilson Poh
School of Materials Science and Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore, 639798
Search for more papers by this authorCorresponding Author
Say Chye Joachim Loo
School of Materials Science and Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore, 639798
Singapore Centre on Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, 637551
E-mail: [email protected]Search for more papers by this authorYi Guang Jerome Lim
School of Materials Science and Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore, 639798
Search for more papers by this authorKwok Choon Wilson Poh
School of Materials Science and Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore, 639798
Search for more papers by this authorCorresponding Author
Say Chye Joachim Loo
School of Materials Science and Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore, 639798
Singapore Centre on Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, 637551
E-mail: [email protected]Search for more papers by this authorAbstract
Anisotropic Janus particles composed of biocompatible polymers have been gaining considerable interest for biomedical applications. Here, the fabrication of hybrid Janus particles via a single-step solvent emulsion technique, potentially for theranostic purposes, is shown. Through this technique, the selective encapsulation of therapeutic and diagnostic agents is streamlined into different “faces” of the Janus structure. This facile technique is used to seamlessly fabricate polymeric-based hybrid Janus particles for theranostic applications with little complexity.
Conflict of Interest
The authors declare no conflict of interest.
Supporting Information
| Filename | Description |
|---|---|
| marc201800801-sup-0001-SuppMat.pdf659.6 KB | Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1J. Hu, S. Zhou, Y. Sun, X. Fang, L. Wu, Chem. Soc. Rev. 2012, 41, 4356.
- 2H. Xie, Z.-G. She, S. Wang, G. Sharma, J. W. Smith, Langmuir 2012, 28, 4459.
- 3A. Kumar, B. J. Park, F. Tu, D. Lee, Soft Matter 2013, 9, 6604.
- 4M. Guix, A. K. Meyer, B. Koch, O. G. Schmidt, Sci. Rep. 2016, 6, 21701.
- 5S. Jiang, Q. Chen, M. Tripathy, E. Luijten, K. S. Schweizer, S. Granick, Adv. Mater. 2010, 22, 1060.
- 6E. Passas-Lagos, F. Schuth, Langmuir 2015, 31, 7749.
- 7S. Lone, I. W. Cheong, RSC Adv. 2014, 4, 13322.
- 8F. Wurm, A. F. Kilbinger, Angew. Chem., Int. Ed. 2009, 48, 8412.
- 9A. R. Abate, M. Kutsovsky, S. Seiffert, M. Windbergs, L. F. Pinto, A. Rotem, A. S. Utada, D. A. Weitz, Adv. Mater. 2011, 23, 1757.
- 10S. Hwang, J. Lahann, Macromol. Rapid Commun. 2012, 33, 1178.
- 11O. B. Garbuzenko, J. Winkler, M. S. Tomassone, T. Minko, Langmuir 2014, 30, 12941.
- 12N. Naseri, H. Valizadeh, P. Zakeri-Milani, Adv. Pharm. Bull. 2015, 5, 305.
- 13Y. L. Fan, C. H. Tan, Y. Lui, D. Zudhistira, S. C. J. Loo, RSC Adv. 2018, 8, 16032.
- 14S. L. Perry, J. J. Higdon, P. J. Kenis, Lab Chip 2010, 10, 3112.
- 15A. L. Lewis, R. R. Taylor, B. Hall, M. V. Gonzalez, S. L. Willis, P. W. Stratford, J. Vasc. Interv. Radiol. 2006, 17, 1335.
- 16P. Mistry, S. Mohapatra, T. Gopinath, F. G. Vogt, R. Suryanarayanan, Mol. Pharmaceutics 2015, 12, 3339.
- 17F. S. Romanski, J. S. Winkler, R. C. Riccobene, M. S. Tomassone, Langmuir 2012, 28, 3756.
- 18A. Neubert, K. Sternberg, S. Nagel, C. Harder, K.-P. Schmitz, H. K. Kroemer, W. Weitschies, J. Controlled Release 2008, 130, 2.
- 19M. S. Surapaneni, S. K. Das, N. G. Das, ISRN Pharmacol. 2012, 2012, 623139.
- 20W. L. Lee, W. M. Guo, V. H. Ho, A. Saha, H. C. Chong, N. S. Tan, E. Widjaja, E. Y. Tan, S. C. J. Loo, Small 2014, 10, 3986.
- 21H. K. Makadia, S. J. Siegel, Polymers 2011, 3, 1377.
- 22N. Rahman, E. Mathiowitz, J. Controlled Release 2004, 94, 163.
- 23A. Zenerino, C. Peyratout, A. Aimable, J. Colloid Interface Sci. 2015, 450, 174.
- 24R. Qiao, C. Yang, M. Gao, J. Mater. Chem. 2009, 19, 6274.
- 25W. Zheng, C. Sun, B. Bai, Polymers 2017, 9, 370.
- 26D. Rehana, A. K. Haleel, A. K. Rahiman, J. Chem. Sci. 2015, 127, 1155.
- 27K. Bastari, M. Arshath, Z. H. M. Ng, J. H. Chia, Z. X. D. Yow, B. Sana, M. F. C. Tan, S. Lim, S. C. J. Loo, J. Mater. Sci.: Mater. Med. 2014, 25, 747.
- 28M. Guix, A. K. Meyer, B. Koch, O. G. Schmidt, Sci. Rep. 2016, 6, 21701.
- 29J.-S. Baek, J. K. Tee, Y. Y. Pang, E. Y. Tan, K. L. Lim, H. K. Ho, S. C. J. Loo, NeuroMol. Med. 2018, 1, 262.
- 30J.-S. Baek, C. C. Choo, N. S. Tan, S. C. J. Loo, Oncotarget 2017, 8, 80841.
- 31D. N. McLennan, C. J. Porter, S. A. Charman, Drug Discovery Today: Technol. 2005, 2, 89.
- 32X. Wang, M. K. Sng, S. Foo, H. C. Chong, W. L. Lee, M. B. Y. Tang, K. W. Ng, B. Luo, C. Choong, M. T. C. Wong, B. M. K. Tong, S. Chiba, S. C. J. Loo, P. C. Zhu, N. S. Tan, J. Controlled Release 2015, 197, 138.
Citing Literature
